Monsanto v. Durnell · ¶56
The Riegel Court concluded that FDA's premarket approval of devices imposed “ `requirements' under” the Act's preemption clause, id., at 322, and therefore that FDA's premarket approval of a medical device preempted state-law claims premised on additional or contrary safety requirements. Id., at 323–325.Read in context ›
preliminary print (page proof)
Source edition
Passage preview. Read in context for the complete text, notes and references.